21st.BIO is a Danish biotechnology company specializing in advanced precision fermentation and synthetic biology. They focus on developing and scaling bioproduction platforms for a wide range of sustainable ingredients, materials, and food products. Their mission is to make bio-based solutions more accessible, efficient, and cost-effective by leveraging cutting-edge technologies, including AI, data science, and automation, to optimize microbial strains and fermentation processes. They partner with companies across various sectors to accelerate the transition to a bio-based economy.
The headquarters serves as the central hub for R&D, strategic operations, business development, and administrative functions, driving the company's innovation in precision fermentation.
Located within the Copenhagen Bio Science Park (COBIS), offering access to state-of-the-art laboratories, pilot-scale fermentation facilities, and a collaborative ecosystem of biotech companies and research institutions.
A science-driven, innovative, and collaborative environment. Employees are typically mission-oriented, focusing on sustainability and technological advancement. The culture encourages problem-solving and cross-functional teamwork.
Its location in COBIS places 21st.BIO at the heart of a leading European life science cluster, facilitating talent acquisition, research collaborations, and industry partnerships.
21st.BIO operates primarily from its headquarters in Copenhagen, Denmark, and its technology and production site in Davis, California, USA. While these are its main physical locations, the company supports a global clientele and collaborates with international partners to advance and implement its precision fermentation technologies worldwide. Their solutions are designed for global applicability in food, materials, and other bio-based industries.
Ole Maaløes Vej 3
Copenhagen N
Capital Region of Denmark
Denmark
Address: 2081 Second Street, Suite 100, Davis, CA 95618, USA
To establish a significant presence in the North American market, facilitate collaborations with U.S.-based partners, tap into the local talent pool, and support clients in the region with advanced bioproduction solutions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, 21st.BIO' leadership includes:
21st.BIO has been backed by several prominent investors over the years, including:
21st.BIO has been actively strengthening its leadership team to support its growth. Notable appointments include a Chief Commercial Officer to drive market expansion. No major C-suite exits have been publicly announced in the last 12 months.
Discover the tools 21st.BIO uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
21st.BIO likely utilizes common professional email formats. The most probable structures involve combinations of first name, last name, and initials with their domain @21st.bio. For instance, using initials or full names.
[first_initial][last]@21st.bio (e.g., tschmidt@21st.bio) or [first].[last]@21st.bio (e.g., thomas.schmidt@21st.bio)
Format
tschmidt@21st.bio
Example
80%
Success rate
21st.bio News • February 20, 2024
21st.BIO announced the appointment of Hansi Licht as its new Chief Commercial Officer (CCO). Licht will be responsible for driving the company's commercial strategy, expanding its market presence, and fostering partnerships to accelerate the adoption of its precision fermentation technologies....more
Biobased Press • January 10, 2024
21st.BIO and Celtic Renewables have entered a strategic partnership to enhance the production of high-value biobased chemicals using advanced fermentation technologies. This collaboration aims to optimize Celtic Renewables' ABE (Acetone-Butanol-Ethanol) fermentation process for producing sustainable chemicals from low-value biological feedstocks....more
TechCrunch • May 25, 2023
21st.BIO secured significant seed funding led by Novo Holdings to advance its mission of making bioproducts, including proteins, more affordable and accessible through its innovative precision fermentation platform. The investment will help scale its technology and expand its capabilities....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including 21st.BIO, are just a search away.